Phototoxicity-induced pain is a major clinical problem triggered by light acting on photosensitising drugs or endogenous porphyrins, notably protoporphyrin IX (PpIX), an intermediary in heme biosynthesis. Protoporphyrin IX accumulates in individuals with erythropoietic protoporphyria and is elevated during photodynamic therapy subsequent to application of 5-aminolevulinic acid (ALA). Pain occurs during irradiation of PpIX and responds poorly to conventional analgesics. Our objective was to develop a model of PpIX phototoxicity pain and investigate the potential of menthol as an analgesic. Application of ALA to the tails of C57 black and SWISS white mice caused PpIX accumulation and nociception during irradiation (630 nm at 3.7 J/cm 2 ). Despite similar PpIX accumulation, C57 mice exhibited less pain behavior compared with SWISS mice because of light absorption by pigmentation. Irradiation of ALA-treated dorsal root ganglion neurons caused phototoxicity-evoked action potentials (APs) in both mouse strains. The antioxidant L-tryptophan increased the light dose required to elicit such APs. By contrast, the addition of keratinocytes to neuronal cultures decreased the threshold for APs, suggesting a requirement for proliferating cells. Inhibition of fatty acid amide hydrolase, selective antagonism of TRPV1 or the application of lidocaine or its quaternary derivative QX-314, reduced AP frequency, whereas antagonism of TRPA1 had no effect. These results suggest that products of singlet oxygen-mediated lipid peroxidation trigger nociceptor activation via TRPV1. Menthol inhibited phototoxicity-evoked APs and reduced pain behavior when applied topically to mice. These findings suggest that menthol might provide pain relief in patients experiencing PpIX-phototoxicity pain caused by photodynamic therapy or erythropoietic protoporphyria.
Introduction
Phototoxicity is relatively common in patients prescribed photoactive drugs and is the basis for photodynamic therapy (PDT). 19, 27, 28, 38 Phototoxicity also occurs in the light-exposed skin of patients having erythropoietic protoporphyria (EPP) in whom the photoactive molecule protoporphyrin IX (PpIX) accumulates. 18, 36 When exposed to light, fluorescent molecules generate reactive singlet oxygen ( 1 O 2 ) from triplet oxygen by a type 2 reaction and free radicals, such as superoxide, by a type 1 reaction. 12 Endogenous antioxidants help overcome cellular damage, but this protection is overwhelmed during phototoxicity leading to cell death. 22 Protoporphyrin IX accumulation is normally restricted by the rate-limiting step at aminolevulinic acid (ALA) synthase, a mitochondrial enzyme within the heme pathway and ferrochelatase, which rapidly inserts ferrous iron into PpIX, thereby limiting its phototoxic potential. Autosomal recessive loss-of-function mutations in the ferrochelatase gene, usually in combination with a low-expressing polymorphic allele, lead to the most common EPP. 2 Protoporphyria can also be caused by rare gain-of-function mutations in the erythroid-specific ALA synthase gene. 13 Protoporphyrin IX phototoxicity is exploited therapeutically in the controlled delivery of topical PDT to treat nonmelanoma skin cancers, such as basal cell carcinoma, precancers, and other diverse skin diseases including actinic keratosis (AK). 27, 28 Protoporphyrin IX accumulates following application of a prodrug, such as ALA. The generation of 1 O 2 during irradiation destroys diseased tissue. However, a burning sensation typically occurs, and pain is the most common adverse effect of PDT. 19, 27, 28, 38 Pain can be mild to severe, displaying marked individual variability.
Blue light (405 nm), often used during PDT for superficial AK, effectively photoactivates PpIX. A recent study demonstrated that 405-nm irradiation itself causes pain associated with activation of TRPA1 and TRPV1 channels in dorsal root ganglion (DRG) neurons, which was enhanced by elevated PpIX. 1 Blue light has limited tissue penetration, and more deeply penetrating red light (630 nm) is often used as an alternative during PDT. Red light alone does not have any effects; however, in the presence of PpIX-mediated photosensitization, the combination causes pain of unknown mechanism. 38 Sponsorships or competing interests that may be relevant to content are disclosed at the end of this article.
Approaches for PDT pain management, such as light interruption, topical local anesthetics, oral analgesics, and cooling, have had limited success. 19, 27, 28, 38 There is a need for more effective PDT pain relief, and experimental models are required to develop new approaches.
Despite its known analgesic properties and wide availability, topical menthol has not previously been investigated as a potential means of pain prevention or relief during PDT. There are a number of reasons why menthol might be a good choice. It evokes a cooling sensation through activation of TRPM8 receptors. 4 This might be advantageous, as skin cooling causes a small reduction in PDT pain. 35 Furthermore, menthol directly inhibits voltageactivated Na 1 channel activity and increases paw withdrawal latency from noxious heat. 21, 30 We developed a mouse model of pain and hyperalgesia evoked by PDT with red light and used DRG neurons to examine the mechanisms involved in PDT phototoxicity-evoked action potentials (APs) and the potential role of topical menthol for PpIX phototoxicity pain prevention.
Methods

Cell culture
Dorsal root ganglia were harvested from NIH SWISS and C57BL/6 mice (postnatal day [8] [9] [10] . Cells were dissociated both enzymatically (collagenase and dispase [4 mg/mL] and papain [40 U/mL]) and physically by trituration. Neurons were plated onto poly-Dlysine-coated and laminin-coated coverslips (13 mm in diameter) in the center of 35-mm dishes (VWR, Leicestershire, United Kingdom), as described previously. 37 Cells were cultured in Dulbecco modified Eagle medium (DMEM) with F-12 nutrient mixture, supplemented with heat-inactivated fetal bovine serum (10%), nerve growth factor (50 ng/mL), and penicillin (100 mg/mL) and streptomycin (100 U/mL) at 37˚C and 5% CO 2 . Dorsal root ganglion cells were maintained in culture for up to 15 days. Human keratinocyte (HaCaT) and human embryonic kidney (HEK) cells were maintained in DMEM, supplemented with fetal bovine serum (5%), nonessential amino acids (1%), penicillin (100 mg/mL) and streptomycin (100 U/mL) at 37˚C and 5% CO 2. For combined cultures, HaCaT cells were plated onto the poly-D-lysine-coated and laminin-coated coverslips on the day preceding DRG dissociation. Harvested DRG cells were plated on HaCaT cell-coated coverslips. Co-cultures were incubated at 37˚C and 5% CO 2 for a further 3 days before recording. For electrophysiological studies, HEK cells were seeded in 35-mm culture dishes. Complementary DNAs encoding rat TRPV1 receptors (Origene, Rockville, MD) or rat TRPA1 receptors (a gift from Dr Gerard Ahern, Georgetown University) were transfected into HEK cells using calcium phosphate precipitation. Reagents were obtained from Invitrogen (Paisley, United Kingdom) or SigmaAldrich (Dorset, United Kingdom).
Flow cytometry
Cells were seeded onto 60-mm dishes and incubated in media in the absence or presence of ALA (1 mM; Sigma-Aldrich) for 4 hours at 37˚C and 5% CO 2 . Cells were washed with phosphate buffered saline (PBS) and harvested using a nonenzymatic cell dissociation solution (Sigma-Aldrich). After centrifugation at 3000 rpm for 5 minutes, cells were resuspended in PBS. Fluorescence mediated by PpIX was measured using flow cytometry. Ten thousand cells per sample were analyzed on a FACScan flow cytometer, using a 15-mW blue (488 nm) argon laser to excite PpIX. Emitted fluorescence was detected at $650 nm. Data were acquired using Cell Quest Pro 5.2.1 (Becton Dickinson Immunocytochemistry Systems, San Jose, CA). Analysis was performed using FlowJo 9.7.5 software (www.treestar.com). Regions of interest containing healthy cell populations were identified on the basis of forward and side light scatter enabling the subsequent production of fluorescence histograms, as described previously. 37 
Protoporphyrin IX irradiation
For in vitro experiments, cells were incubated (4-7 hours) in the dark, in media with or without ALA (1 mM). The ALA incubation time is in keeping with the conditions used in patients, where ALA would usually be applied for 3 to 6 hours. Cells were irradiated (20 minutes) using a diode laser at 630 nm, with an irradiance of 96 mW/cm . The light dose required to produce reliable pain behaviour in SWISS mice was determined empirically. The light doses are within the range used clinically during PDT. 14 
Electrophysiology
The patch-clamp technique was used to record whole-cell and outside-out or cell-attached patch currents (voltage-clamped at 0 and 260 mV, respectively), and APs (current-clamp). Borosilicate glass recording electrodes when filled with intracellular solution had resistances of 1.8 to 3 MV. For excised patch recordings, the electrode solution contained (in mM) 140 CsCl, 2 MgCl 2 , 11 ethylene glycol tetraacetic acid (EGTA), 3 Mg-ATP, and 10 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES) (pH 7.4 with CsOH). The extracellular solution contained (in mM) 140 NaCl, 4.7 KCl, 1.2 MgCl 2 , 2.5 CaCl 2 , 10 glucose, and 10 HEPES (pH 7.4 with NaOH). The extracellular solution was used within the electrode during cell-attached recordings. Currentclamp recordings used an electrode solution containing (in mM) 140 potassium gluconate, 10 NaCl, 2.8 KCl, 2 MgCl 2 , 0.1 CaCl 2 , 1.1 EGTA, and 10 HEPES (pH 7.4 with KOH). The extracellular solution was the same as that used in voltage-clamp recordings. Current-clamp data were corrected for the calculated liquid junction potential. Electrophysiological recordings were performed under subdued lighting. The diode laser was used to examine the effects of irradiation under control conditions or after incubation with ALA (1 mM). All electrophysiological data were recorded using an Axopatch 200A amplifier (Molecular Devices, Sunnyvale, CA). Data were low pass filtered at 2 kHz, digitised at 8 kHz using a Digidata 1322A interface, acquired, and analysed using pClamp 10.2 software (from Molecular Devices). Action potentials were detected by the threshold method and verified by visual inspection. Instantaneous AP frequencies were determined, and bursts were defined as .5 consecutive events with an instantaneous frequency .0.1 Hz. The latency to response was determined as the time taken for irradiation to generate a burst of APs. The frequency of APs was determined during the entire 1200 seconds irradiation.
Cell viability assay
Viability was assessed using 3-(4,5-dimethyl-2-thiazolyl)-2,5-diphenyl-2H-tetrazolium bromide (MTT). Control or PDT-treated cells were incubated (2 hours) in media containing 0.6 mg/mL MTT. Cells were washed with PBS, and images were digitally captured using a Moticam 2500 camera with Motic Images Plus 2.0 software (Microscopy Supplies and Consultants Ltd, Fife, United Kingdom).
Confocal imaging
Experiments were performed in the Light Microscopy Core Facility. Protoporphyrin IX fluorescence was visualised in DRG neuronal cultures using confocal microscopy. Dorsal root ganglion cultures were treated with ALA (1 mM for 4 hours). Cells were then examined under a Leica TCS SP-5 confocal microscope (Leica, Newcastle, United Kingdom) at 340 magnification in DMEM lacking phenol red. Protoporphyrin IX was excited at 405 nm, and the emitted fluorescence was collected between 610 and 650 nm.
Behavioral studies
Mice were bred, maintained, and housed in the Ninewells Hospital Medical Resource Unit in accordance with the University of Dundee's Ethics Committee and UK Home Office regulations, with an appropriate project license. They had access to food and water ad libitum with 12 hours cycles of light and dark; the temperature was maintained between 19˚C and 21˚C. All experiments were performed in the light phase. Studies were performed in the Behavioural Neuroscience Core Facility. NIH SWISS and C57BL/6 mice were habituated to handling 3 days before the commencement of behavioral studies. Soft white paraffin (50 mg; vehicle) or ALA (20% wt/wt; Mandeville Medicines, Buckinghamshire, United Kingdom) cream was applied to tails. Mice were kept in darkness for 4 hours before irradiation, and behavioral studies were conducted under subdued lighting. As described previously, 20 laser diode fluorescence spectroscopy was used to confirm the conversion of ALA uptake to PpIX. Light at a wavelength of 405 nm was used to excite PpIX within mouse tails. Emitted fluorescence was acquired onto a PC for analysis (LabVIEW software; National Instruments, London, United Kingdom). Protoporphyrin IX-mediated fluorescence was detected between 600 to 750 nm, with peak fluorescence at 634 nm. Measurements from human forearm were performed alongside mouse measurements for comparison. In some cases, mouse PpIX fluorescence was normalised to that of human PpIX fluorescence acquired on the same day (expressed as % fluorescent units). Tails were exposed to light emitted from a diode laser (630 nm, irradiance 62 mW/cm 2 , 60 seconds, light dose 3.72 J/cm 2 ), to assay PpIX phototoxicity pain. Pain behavior was assayed by measuring the time spent in tail lifting, holding, and licking the tail within 60 seconds after laser exposure. Experiments examining the potential analgesic action of menthol were blinded. To habituate animals and investigators to menthol odour, a vapour source was present throughout the period of these experiments. Aqueous cream (0.4 g) or menthol (2% or 16%) was applied to tails 10 minutes before irradiation. For studies examining tail withdrawal latencies, tails were exposed to temperatures ranging from 37˚C to 53˚C.
Temperature measurements
The laser-induced temperature increase within the recording chamber was determined using a digital thermo-hygrometer (VWR, Leighton Buzzard, United Kingdom). The temperature was recorded every 30 seconds for the duration of irradiation. An infrared thermoIMAGER 160 camera and TIM Connect software (Micro-Epsilon UK Ltd, Birkenhead, United Kingdom) were used to determine the effect of laser irradiation on mouse tail temperature recorded continuously over a period of 60 seconds.
Statistical analysis
Data are represented as mean 6 SEM. Statistical analyses were performed using IBM SPSS 22. Analyses of tail withdrawal data were performed using the Wilcoxon signed-rank test or the Kruskal-Wallis test. Other pairwise analyses of mean values were performed using the t test. One-way or 2-way analyses of variance (ANOVAs) were used to analyse multiple groups, as appropriate. Multiple comparison corrections were performed using either Dunnett or Tukey correction for 1-way ANOVA, or Bonferroni correction for 2-way ANOVA. Correlation between PpIX emission and pain behaviour was performed using a Pearson correlation test. Exact P values are reported where possible (except when P , 0.0001), and data were considered statistically significant when P , 0.05.
Drug application
For in vitro experiments, drugs, made fresh from stocks on the day of experimentation, were applied either to the bath before irradiation (AMG-9810, HOE140, AA-5-HT, PF-3845, lidocaine, QX-314, and menthol), or focally by pressure ejection (PicoSpritzer II; General Valve Corp, Fairfield, NJ) from a glass micropipette (capsaicin and QX-314). Drug application to outside-out patches of HEK cells containing TRPV1 receptors was achieved using the 3-pipe Perfusion Fast-Step system (Warner Instruments, San Francisco, CA), as described previously. 3 Menthol cream (2% and 16%) was made fresh on the day of experimentation. Menthol was dissolved in ethanol (100%) before mixing into aqueous cream. The vehicle consisted of the equivalent volume of ethanol mixed into aqueous cream.
Results
Photodynamic therapy-induced pain behavior in mice
We examined the effect of laser irradiation (630 nm, 3.7 J/cm 2 ) and ALA applied topically (4-6 hours) on the tails of NIH SWISS white mice and C57BL/6 black mice. Neither topical ALA (SWISS; n 5 35; C57; n 5 17; data not shown), nor laser irradiation alone (SWISS; n 5 30; C57; n 5 10) caused discernible pain behaviour (see Methods) in either mouse strain (Fig. 1A) . The average duration of pain behavior increased from 0.4 6 0.2 seconds (n 5 30) in vehicle-treated SWISS mice to 20 6 3 seconds (n 5 30) in ALA-treated mice during 60 seconds after laser irradiation of their ALA-treated tails (Fig. 1A) . After ALA and laser irradiation, 5 of 10 C57 mice also displayed pain behaviour. The duration of pain behaviour increased from none in vehicle-treated C57 mice (n 5 10) to 4 6 2 seconds (n 5 10) in ALA-treated mice. In both strains, pain behavior ceased within 5 minutes, suggesting that the underlying pain was acute and transient.
We compared the influence of ALA and vehicle treatment on laser irradiated tails between SWISS and C57 mice using a 2-way ANOVA. The analysis revealed a significant difference in both tail treatment (vehicle vs ALA; F 1,76 5 22.1; P , 0.0001) and the strain of mouse (SWISS vs C57; F 1,76 5 11.2; P 5 0.001) on pain behavior. There was also a statistically significant interaction between tail treatment and mouse strain (F 1,76 5 10.2; P 5 0.002). This suggests that the increase in duration of pain behavior after ALA and laser treatment differed depending on the strain of mouse used. A simple effects comparison using the Bonferroni correction revealed that the pain behavior exhibited by SWISS mice was significantly (P , 0.0001) more prolonged than that of C57 mice after treatment with ALA (Fig. 1A) .
Therefore, the data suggest that SWISS mice are more susceptible to PDT-induced pain.
Pigmentation reduces protoporphyrin IX-mediated fluorescence and associated pain
We observed PpIX emission noninvasively using fluorescence spectroscopy with fibre optic-coupled laser excitation at 405 nm (Fig. 1B) . Compared with vehicle-treated control mouse tails, the characteristic PpIX emission spectrum was enhanced by ALA treatment to levels similar to those achieved in the ALA-treated human forearm (Fig. 1B) . We quantified PpIX emission by measuring the peak fluorescence at 634 nm (see Methods) and normalising this value to that measured from a human forearm (as % control fluorescence units). Protoporphyrin IX emission was evident in the ALA-treated tails of both C57 and SWISS mice, after laser irradiation (Fig. 1C) . By contrast, mice treated with vehicle exhibited negligible PpIX emission (Fig. 1C) . Both C57 mice and SWISS mouse tails showed increased PpIX emission after ALA treatment. However, similar to the pain behavior data (Fig. 1A) , PpIX fluorescence emission from ALA-treated tails of C57 mice was less (only ;25%) compared with SWISS mouse tails (Fig. 1C) . We, therefore, analysed the PpIX fluorescence emission data using a 2-way ANOVA. Our analysis revealed, like the pain behaviour above, that both treatment (F 1,100 5 56.8) and mouse strain (F 1,100 5 23.2) significantly influenced PpIX emission (P , 0.0001 for both). We also found a significant interaction between tail treatment and mouse strain (F 1,100 5 19.1; P , 0.0001). This suggests that the increase in PpIX emission differs after ALA and laser treatment, depending on the mouse strain. Indeed, a simple effects comparison with a Bonferroni correction revealed that the difference in PpIX emission between the tails of SWISS and C57 mice to be significant (P , 0.0001), after ALA treatment (Fig. 1C) . Irradiation using a Wood lamp also revealed greater visible fluorescence emission from ALA-treated tails of SWISS mice compared with those of C57 mice (supplemental Fig. 1 , available online at http:// links.lww.com/PAIN/A501). In addition to the tails, fluorescence was observed in the paws, noses, and ears of both mouse strains indicating the systemic accumulation of PpIX. Pigmentation in C57 mice may absorb irradiation leading to reduced PpIX fluorescence. This could account for the lower level of PpIX-irradiation pain (Fig. 1A) . Pigmentation is the greatest in the ears and tails of C57 mice, with lower levels in their paws. We, therefore, compared PpIX emission for each of these tissues after treatment of tails with ALA in C57 and SWISS mice. Consistent with a role for pigmentation in the diminished PpIX fluorescence of C57 tails, we found a significant (P 5 0.006; t test) difference in PpIX emission from the ears between C57 and SWISS mice, in which visual inspection revealed a clear difference in pigmentation (supplemental Fig. 1 , available online at http://links.lww.com/PAIN/ A501), but no significant difference (P 5 0.12; t test) in the paws, in which neither strain exhibited obvious pigmentation (Fig. 1D) . We further explored a role for pigmentation in PpIX emission, by applying black ink to the tails of SWISS mice. We compared PpIX emission from ALA-treated tails from C57, SWISS, and black ink-stained SWISS mice tails. A 1-way ANOVA revealed a significant difference (F 2,12 5 82.7; P , 0.0001) between PpIX emission (Fig. 1D) . A post hoc Dunnett comparison showed that both C57 mice tails and black ink-stained SWISS mice tails had significantly lower (P , 0.0001) PpIX emission than control SWISS mice tails (Fig. 1D) . Taken together, our data are consistent with the hypothesis that pigmentation absorbs irradiation, leading to lower PpIX fluorescence emission and, in turn, less pain behavior (Fig. 1A) .
The in vivo data demonstrate that neither PpIX production nor 630-nm irradiation alone is sufficient to generate pain in mice. By contrast, PpIX fluorescence evoked by irradiation was associated with quantifiable pain behavior. Although PpIX fluorescence was required for pain behavior, there was no correlation (P 5 0.95; Pearson r coefficient 5 0.013) between the level of PpIX fluorescence emission and the extent of pain behavior (Fig. 1E) . Having established that SWISS mice exhibited robust PDT pain after ALA treatment, subsequent behavioral experiments were performed using this approach.
Protoporphyrin IX phototoxicity causes thermal hyperalgesia
Protoporphyrin IX phototoxicity pain in humans is described as a burning sensation implicating sensitisation or activation of thermal nociceptive pathways. 19, 27, 28, 38 We explored this by investigating the effect of PpIX irradiation on subsequent tail withdrawal from heated water. Baseline thermal withdrawal latencies were established by tail immersion in water heated to between 37˚C and 53˚C (supplemental Fig. 2 , available online at http://links.lww.com/PAIN/A501). At 53˚C, the average tail withdrawal latency was 6 6 2 seconds (n 5 15), with 14 of 15 mice withdrawing within less than 30 seconds. An intermediate tail withdrawal latency of 24 6 2 seconds (n 5 15) occurred with water at 48˚C, with 9 of 15 mice withdrawing in ,30 seconds. This temperature was chosen to examine the effects of PpIX irradiation on thermal sensitivity. We subsequently examined the tail withdrawal latencies of mice treated with vehicle cream with laser irradiation, ALA cream without laser irradiation, and ALA cream with laser irradiation. The mean tail withdrawal latencies are summarised in Figure 1F . A Kruskal-Wallis test revealed significant (P 5 0.018) differences in tail withdrawal latencies (Fig.  1F) . Post hoc comparisons revealed significant (P 5 0.029) reduction in tail withdrawal latency in mice exposed to both ALA cream and laser irradiation vs those exposed to vehicle cream and laser (Fig. 1F) . Ten of 15 mice responded in this group. No changes in tail withdrawal latencies were observed in mice exposed to irradiation only (n 5 15) or ALA cream only (n 5 5; Fig.  1F) . A PDT-induced reduction in withdrawal latency, without an obvious change in the proportion of mice responding, is consistent with a heightened thermal pain response (hyperalgesia).
Protoporphyrin IX phototoxicity evokes action potentials in dorsal root ganglion neurons
Primary afferent neurons within DRG transmit nociceptive pain from peripheral sites, such as the tail, to the spinal cord. Confocal images of DRG cultures reveal PpIX-mediated fluorescence in cells after ALA (1 mM) treatment for 4 hours (Fig. 2A) . Flow cytometry using dissociated DRG cultures revealed that cells treated with ALA (1 mM for 4 hours) produced PpIX fluorescence emission that was not seen in untreated cells (Fig. 2A) . These data demonstrate that ALA, when applied directly, leads to the production of PpIX in DRG cultures.
We examined responses of small DRG neurons (,25 mm) to ALA either alone or in combination with laser irradiation (630 nm) using the cell-attached configuration to monitor APs. This approach preserves the intracellular milieu, while APs are monitored as a combination of resistive and capacitive currents. 15 Spontaneous APs occurred very rarely in recordings from SWISS and C57 DRG neurons (grown for 1-15 days in vitro) under control conditions or in recordings from neurons exposed to ALA (1 mM, 4-7 hours) before irradiation (Fig. 2B, C) . By contrast, during laser irradiation (630 nm), neurons from both mouse strains exposed to ALA exhibited bursts of frequent APs (Fig. 2B,  C) . Dorsal root ganglion neurons from SWISS and C57 mice exhibited similar responses to PpIX irradiation. Subsequent in vitro experiments were performed using DRG neurons from C57 mice.
Although 97% of neurons responded to PpIX irradiation (day 4-15 in vitro), there was considerable variability in the latency to the first burst of APs (486 6 20 seconds; n 5 135), which equates to a mean light dose of 47 6 2 J/cm 2 required to evoke a response during the 1200 seconds laser exposure (total light dose 5 115 J/cm 2 ). The instantaneous frequency of APs was 11.6 6 1.3 Hz (day 7 in vitro). The mean frequency of firing during the entire period of irradiation was 0.23 6 0.03 Hz. Interestingly, despite the known cellular toxicity of PpIX irradiation, resulting from the release of reactive oxygen species (ROS), 41 most DRG neurons survived the full 1200 seconds of laser exposure.
Using the whole-cell current-clamp recording configuration, we examined the effects on membrane potential of ALA and irradiation either alone or in combination (Fig. 2D) . Dorsal root ganglion neurons exhibited infrequent spontaneous APs under control conditions. Neither ALA treatment (257 6 3 mV, n 5 7) nor laser irradiation alone (260 6 3 mV, n 5 5) affected the resting membrane potential or frequency of spontaneous APs (Fig. 2D) . However, laser irradiation of DRG neurons treated with ALA (4-7 hours) led to a sustained depolarisation (of 9 6 1 mV, n 5 3) and the appearance of frequent APs (Fig. 2D) .
Taken together, these in vitro data demonstrate that neither PpIX production nor laser irradiation alone is sufficient to generate APs in nociceptive neurons. However, a combination of the 2 leads to depolarization of neurons initiating bursts of APs.
Singlet oxygen participates in phototoxicity-evoked excitation of dorsal root ganglion neurons
We investigated the possible involvement of ROS in the activation of nociceptive neurons using L-tryptophan, an antioxidant that prevents cell death induced by PpIX irradiation by scavenging 1 O 2 and tempol, a superoxide scavenger. 32 Incubation of ALAtreated DRG neuron cultures in the presence of L-tryptophan (2 mM) significantly increased (P 5 0.021; t test) the light dose required for the initiation of APs from 39 6 6 J/cm 2 (n 5 9) to 67 6 9 J/cm 2 (n 5 8) by PpIX irradiation, without significantly affecting the frequency of APs (Fig. 3A) . By contrast, tempol (1 mM) had no effect on either parameter. These data reveal an involvement of 1 O 2 in the phototoxicity-evoked excitation of DRG neurons.
Proliferating cells initiate protoporphyrin IX phototoxicity-evoked action potentials in dorsal root ganglion neurons
The activation of nociceptive neurons by PpIX irradiation could be caused directly by 1 O 2 generated within the neuron or through the release of mediators from adjacent glial cells. We took advantage of the relative scarcity of glial cells in the vicinity of DRG neurons on days 1 and 2 in vitro to investigate whether their presence influences the activation of APs by PpIX phototoxicity (supplemental Fig. 3 , available online at http://links.lww.com/PAIN/A501). Most neurons begin to respond to PpIX irradiation on day 3 in vitro, in keeping with a requirement for proliferating nonneuronal cells. The mean light dose required to activate the first burst of APs decreased from day 3. We performed a 1-way ANOVA to compare the light dose required to trigger the first burst of APs with the number of days in culture (F 10,153 5 5.0; P , 0.0001). A post hoc Dunnett comparison revealed a significant reduction in light dose from day 5 (all P , 0.0001 vs day 2; Fig. 3B ). Action potential frequency (Fig. 3C) and the proportion of cells exhibiting bursts of APs (Fig. 3D) increased from day 3. A 1-way ANOVA revealed significant changes in AP frequency with the number of days in culture (F 11,161 5 2.8; P 5 0.002). The increase in AP frequency reached statistical significance (post hoc Dunnett comparison vs day 1) on days 6 (P 5 0.044), 7 (P 5 0.013), and 9 (P 5 0.007; Fig. 3C ). This coincides with the proliferation of nonneuronal cells (supplemental Fig. 3 , available online at http://links.lww.com/PAIN/A501).
We further explored a role for proliferating nonneuronal cells using transformed HaCaT skin cells. 7 Exposure of HaCaT cells to ALA caused the production of PpIX as evidenced by fluorescence emission (supplemental Fig. 4A , available online at http://links.lww. com/PAIN/A501). Laser irradiation after exposure to ALA led to substantial cell death (supplemental Fig. 4B , available online at http://links.lww.com/PAIN/A501). We investigated whether growing DRG neurons on HaCaT cells influences the activation of nociceptors by PpIX irradiation. The light dose required to activate the first burst of DRG APs after irradiation was dramatically decreased by the presence of HaCaT cells (Fig. 3E) . The latency to the first burst significantly decreased (P , 0.0001; t test) from 778 6 121 seconds (n 5 5) in the absence to 63 6 22 seconds (n 5 9) in the presence of HaCaT cells. This corresponds to a significant reduction (P , 0.0001; t test) in the threshold light dose required to produce APs in nociceptive neurons from 75 6 12 J/cm 2 to 6 6 2 J/ cm 2 ( Fig. 3E) . By contrast, the frequency of neuronal firing was unaffected by HaCaT cells (data not shown). Taken together, these data suggest that PpIX irradiation-evoked excitation of DRG neurons requires the generation of ROS by proliferating cells.
TRPV1 inhibition suppresses protoporphyrin IX phototoxicity-evoked action potentials
The in vivo data suggest that PpIX irradiation causes thermal hyperalgesia (Fig. 1F) . This observation, together with patient reports that PpIX-mediated pain resembles a burning sensation, implicates the involvement of the heat-activated ion channel, TRPV1, a mediator of thermal pain on primary afferent nociceptors. 19, 27, 28, 38 Indeed, a recent study demonstrated that both TRPV1 and TRPA1 ion channels are activated by PDT with blue light. 1 We examined the effect of AMG-9810 (1 and 3 mM), a TRPV1 antagonist, 26 on phototoxicity-evoked APs initiated by irradiation with red light. AMG-9810 caused a concentration- dependent inhibition of APs, with 3 mM AMG-9810 significantly (P 5 0.001; t test) reducing the frequency of APs (Fig. 4A) .
We explored the selectivity of AMG-9810 (3 mM) by applying the antagonist to either TRPV1 or TRPA1 receptors, while recording currents evoked by capsaicin (1 mM) and carvacrol (100 mM), respectively. AMG-9810 inhibited currents mediated by both TRPV1 (45% 6 5% inhibition, n 5 3) and TRPA1 (22% 6 12% inhibition, n 5 5) receptors (Fig. 4B) . Next, we used the same approach to explore the selectivity of the TRPA1 antagonist, HC-030031. HC-030031 (10 mM) blocked currents mediated by TRPA1 (89% 6 5% inhibition, n 5 3), but had no effect on currents mediated by TRPV1 receptors (2% 6 1% inhibition, n 5 4; Fig. 4C ). Therefore, we used HC-030031 to determine whether there is a role for TRPA1 in phototoxicity-evoked APs. HC-030031 (10 mM) had no significant effect on either the threshold light dose (P 5 0.2) or AP frequency (P 5 0.5; Fig. 4D ).
Taken together, the data implicate the involvement of TRPV1 receptor activity in PDT-mediated DRG activation.
Heat is not responsible for protoporphyrin IX phototoxicity-evoked TRPV1 activity
TRPV1 channels on primary nociceptive neurons integrate diverse signals including noxious heat, inflammatory mediators, and lipid metabolites. 26 These mediators of pain can activate TRPV1 channels in their own right and/or modulate thermal activation. TRPV1 channels have a thermal activation threshold of .40˚C, which falls in the presence of inflammatory mediators and other sensitizers. 26, 31 We explored whether heat may play a role in the PpIX irradiationevoked excitation of nociceptive neurons. An irradiation light dose of 115 J/cm 2 , equivalent to the maximum exposure of DRG neurons, caused only a 1.3˚C temperature increase in the recording chamber (Fig. 5A) . Furthermore, the use of a thermal imaging camera revealed that laser irradiation (3.7 J/cm 2 ) of SWISS mouse tails elevated temperature by ,2˚C (Fig. 5B) . Neither the in vivo nor the in vitro temperature increase is sufficient to reach the thermal threshold of TRPV1 activation. 9 This presumably explains why laser irradiation alone fails to initiate either pain (Fig. 1A) or APs (Fig. 2B-D) . However, PpIX irradiation may cause the release of thermal sensitizers and/or direct activators of TRPV1 channels on nociceptive neurons.
Bradykinin is a known sensitizer of TRPV1 channels to heat through activation of bradykinin B2 receptors. 26 The B2 antagonist HOE140 (1 mM, n 5 15) had no effect on PpIX phototoxicity-evoked APs recorded from DRG neurons (Fig. 5C) . These data suggest that B2 receptor activation is not required for thermal sensitization of TRPV1 channels during PpIX phototoxicity.
Evidence for an involvement of lipid metabolites in protoporphyrin IX irradiation-evoked action potentials
We next examined whether there is a role for lipid metabolites in PpIX irradiation-evoked excitation of DRG neurons. Narachidonoyl serotonin (AA-5-HT) inhibits fatty acid amide hydrolase (FAAH) when applied at micromolar concentrations, thereby reducing production of endogenous lipid metabolites that may activate and/or sensitize TRPV1 channels. 6, 24 Furthermore, when applied at nM concentrations, AA-5-HT has been reported to inhibit intracellular Ca 21 increases caused by capsaicinevoked activation of recombinant TRPV1 receptors. 24 AA-5-HT (100 nM) had no significant effect on the threshold light dose or the frequency of PpIX sensitivity-evoked APs when applied to DRG neurons (n 5 5; data not shown). However, a higher concentration of AA-5-HT (1 mM; n 5 8) significantly inhibited AP frequency (P 5 0.031; t test), without affecting the light dose required to initiate the first burst of APs (Fig. 5D) . Furthermore, AA-5-HT (1 mM) failed to inhibit currents mediated by recombinant rodent TRPV1 channels recorded from outside-out patches excised from HEK cells (n 5 4; Fig. 5E ), demonstrating that AA-5-HT (1 mM) is inactive at TRPV1 channels. We also tested the selective FAAH antagonist, PF-3845 (2 mM; n 5 12) which, like AA-5-HT, significantly inhibited AP frequency (P 5 0.004; t test), without affecting the threshold light dose (Fig. 5D) . Taken together, the data suggest that FAAH metabolites liberated by PpIX irradiation activate TRPV1 channels leading to excitation of APs in DRG neurons.
Local anaesthetic suppression of protoporphyrin IX phototoxicity-evoked action potentials
Nerve blockade by local anesthetics inhibits pain associated with PDT. 38 We examined whether lidocaine affects PpIX phototoxicity-evoked APs in DRG neurons. Lidocaine (100 mM; n 5 5) inhibited AP frequency (P 5 0.04; t test) without significantly affecting the threshold light dose (Fig. 6A) . Lidocaine also reduced the percentage of cells that responded to PDT from 100% to 60%.
QX-314 is a positively charged quaternary lidocaine derivative that is unable to cross the DRG cell membrane directly and does not affect voltage-activated Na 1 channels when applied extracellularly, but can gain access to the inside of cells through open TRPV1 or TRPA1 channels. 5, 8 Consistent with this, when applied concomitantly, QX-314 (5 mM) inhibited APs evoked by capsaicin (30 mM; Fig. 6B ). QX-314 (5 mM; n 5 9), applied to the recording chamber, also significantly (P , 0.0001; t test) inhibited PpIX irradiation-evoked AP frequency without affecting the threshold light dose (Fig. 6C) and reduced the percentage of cells that responded to PDT from 100% to 67%. Since TRPA1 receptors do not participate in phototoxicity-evoked APs (Fig. 4D) , these data support the hypothesis that TRPV1 channels enable intracellular access of QX-314. However, we cannot rule out the possibility of an alternative route of QX-314 entry. 8 
Menthol suppresses protoporphyrin IX phototoxicity-evoked action potentials and pain
Menthol causes a cooling sensation by activating TRPM8 receptors and also exhibits local anesthetic effects through inhibition of voltage-activated Na 1 channels on nociceptive neurons. 30 We examined whether menthol (300 and 600 mM) inhibits PpIX irradiation-evoked APs recorded from DRG neurons. Menthol inhibited AP frequency in a concentrationdependent manner (Fig. 7A) . There was a statistically significant reduction of AP frequency (with respect to control) at 600 mM (P , 0.035; t test). Also, the percentage of cells that responded to PDT was reduced by menthol (600 mM) from 100% to 33%. Menthol (300 mM) had no effect on the threshold light dose; however, the reduction in the number of cells responding in the presence of 600 mM menthol precluded analysis of the average threshold light dose in this case.
We next investigated whether menthol affects PpIX phototoxicity-evoked pain behavior in mice. The application of menthol (16%) in aqueous cream had no effect on PpIX-mediated fluorescence determined using the photospectrometer with fibre optic-coupled laser excitation at 405 nm (Fig. 7B) . The application of menthol (2% and 16%) to the tails of SWISS mice 600 seconds before laser (630 nm, 3.7 J/cm 2 ) irradiation caused a dose-dependent reduction in the duration of pain behaviour (Fig. 7C) . Vehicle-treated mice did not respond to irradiation with pain behaviour (0.3 6 0.3 seconds; n 5 15), whereas ALAtreated mice treated with aqueous cream 600 seconds before laser irradiation exhibited pain behaviour (28 6 4 seconds; n 5 15; Fig. 7C ), consistent with our previous observations (Fig. 1A) . By contrast, ALA-treated mice receiving 2% or 16% menthol displayed pain behaviour lasting 11 6 3 seconds (n 5 10) and 8 6 2 seconds (n 5 10), respectively. A 1-way ANOVA revealed a significant (F 3,46 5 22.9; P , 0.0001) difference in mean pain behaviour duration (Fig. 7C) . A post hoc Dunnett comparison (vs ALA-treated mice receiving aqueous cream vehicle) demonstrated a significant reduction in pain behaviour in mice receiving 2% or 16% menthol (both P , 0.0001). These data suggest that menthol is an effective analgesic for treating PpIX irradiationevoked pain.
Discussion
Pain caused by drug-induced phototoxicity is a widely encountered problem in clinical medicine. Accumulation of PpIX is a leading cause of phototoxicity, resulting in acute pain during light exposure both in individuals having the most common inherited cutaneous porphyria, erythropoietic protoporphyria (EPP), and in most patients receiving PDT to treat skin diseases, such as skin cancers and precancers. 19, 27, 28, 38 Approximately 20% of the UK population aged $ 60 is affected by actinic keratosis, 17, 25 and we estimate that ;33% may benefit from PDT. Furthermore, in Caucasians, basal cell carcinoma is the most common cancer, with ;110,000 UK adults developing the disease each year. 34 Similarly, around a third may benefit from PDT. Cutaneous porphyrias are less common (in Scotland ;1 in 10,000 and only 7.6 in 100,000 being EPP 11 ). Nevertheless, porphyrias have a major health impact, with lifelong symptoms. Thus, porphyrin-induced pain represents a significant unmet clinical need.
We developed an in vivo mouse behavioral model of pain evoked by PpIX phototoxicity initiated by 630-nm light and investigated its molecular mechanisms in vitro using cultured primary afferent DRG neurons. Using these approaches, we examined the underlying molecular mechanisms and identified menthol as a topical analgesic, which may be effective in the treatment of pain associated with PpIX-induced phototoxicity.
Protoporphyrin IX phototoxicity-induced pain behavior in mice was characterised by tail lifting, holding, and licking after light exposure. The highly pigmented tails of C57 mice exhibited lower PpIX-mediated fluorescence, and there was less pain behaviour than was observed with SWISS mice that lacked pigmentation. By contrast, the level of PpIX fluorescence in the less pigmented paw skin was similar in white and black mice, demonstrating that there was no difference in the abilities of the 2 mouse strains to synthesize PpIX in response to topical ALA. Instead, skin pigmentation absorbs the irradiation required to elicit PpIX excitation. Indeed, a-melanocyte-stimulating hormone and similar drugs that cause melanin accumulation reduce the photosensitivity of patients with cutaneous porphyrias. 16, 36 Protoporphyrin IX phototoxicity in SWISS mice also caused thermal hyperalgesia as evidenced by a reduction in tail withdrawal latency from hot water compared with mice that received either laser or photosensitizer alone. A heightened thermal response could be caused by PpIX phototoxicity-evoked activation of TRPV1 channels on primary afferent nociceptive DRG neurons. Consistent with this, PpIX phototoxicity induced APs in cultured DRG neurons, which were reduced in frequency to negligible levels by the TRPV1 antagonist AMG-9810 or extracellular application of the quaternary lidocaine derivative QX-314. Extracellular QX-314 can enter nociceptive neurons expressing active TRPV1 channels causing blockade of their voltage-activated Na 1 channels. 5 In contrast to the blockade by the TRPV1 antagonist, the TRPA1 antagonist HC-030031 had no effect on AP frequency. This suggests that the activation of APs, evoked by PpIX phototoxicity during irradiation by 630-nm light, is mediated through TRPV1 and not TRPA1 receptors.
TRPV1 channels can be activated by a variety of stimuli including noxious heat. 9, 26, 40 However, the temperature of both the mouse tail and the recording chamber during in vivo and in vitro laser exposure, respectively, remained well below the threshold for TRPV1 activation. Therefore, it is unlikely that 630-nm irradiation provides a thermal stimulus for TRPV1 activation. In keeping with this, red light alone neither caused acute pain behavior nor thermal hypersensitivity. Inflammatory mediators, such as bradykinin, sensitize TRPV1 channels, reducing their thermal activation threshold. 9, 26 However, the bradykinin receptor antagonist, HOE140, did not affect PpIX-evoked APs in DRG neurons suggesting that bradykinin is not involved.
Lipid metabolites also play a role in TRPV1 channel activation and sensitization to heat pain. 31 Furthermore, FAAH inhibitors, which inhibit the metabolism of the endocannabinoid, anandamide, to arachidonic acid, are analgesic. 10 In keeping with a role for fatty acid metabolites downstream of FAAH in PpIX phototoxicity pain triggered by red light, the FAAH inhibitor, AA-5-HT, reduced AP frequency in DRG neurons. AA-5-HT did not directly antagonise recombinant rodent TRPV1 receptors, implying that its inhibition of PpIX-evoked APs is mediated through altered lipid metabolism. In support of this hypothesis, the selective FAAH antagonist, PF-3845, also inhibited APs. Several metabolites downstream of FAAH sensitize and/or activate TRPV1 channels including arachidonic acid, Nacylethanolamines and prostaglandins. 9, 26 These lipid metabolites are prime candidates as mediators of PpIX phototoxicity pain associated with red light. It is possible that FAAH antagonists might be of benefit for treating PDT pain. Additional experiments investigating whether FAAH antagonists reduce pain behaviour in mice will be important to explore this possibility.
Several lines of evidence suggest that the source of the lipid metabolite responsible for TRPV1 receptor activation is unlikely to be the DRG neuron itself. The threshold light dose required for PpIX-evoked APs was greatly diminished by an increased density of proliferating nonneuronal cells. This was most clearly demonstrated by co-culturing DRG neurons with human keratinocyte HaCaT cells, which dramatically reduced the threshold light dose for PpIX-evoked APs in DRG neurons. This suggests that the mediator of TRPV1 receptor activation is released from proliferating cells during PpIX phototoxicity. The demonstration that the 1 O 2 scavenging antioxidant L-tryptophan increases the threshold light dose for PpIX-evoked APs suggests that ROS, generated by PpIX fluorescence in proliferating cells, triggers the release of a TRPV1 activator. The observation that the superoxide scavenger tempol had no effect on PpIX phototoxicity-evoked APs suggests that 1 O 2 , specifically, is implicated in the pain associated with PpIXinduced phototoxicity.
Dorsal root ganglion neurons are remarkably resistant to PpIX phototoxicity because of high levels of 1 O 2 scavenging antioxidants, 41 which likely limits both the availability of 1 O 2 and the autocrine generation of lipid metabolites. Instead, phototoxicity-evoked pain initiated by red light appears to require the paracrine action of lipid metabolites released from proliferating cells.
It is interesting that the excitatory response in whole-cell recordings from DRG neurons was more sustained than that observed using the cell-attached configuration. A possible explanation for this could be desensitization of TRPV1 channels, which is known to be strongly influenced by Ca 21 accumulation. 29 It is possible that there is greater Ca 21 buffering capacity in the whole-cell configuration, by virtue of the electrode solution, which may limit TRPV1 desensitization. In future behavioral experiments, it will be interesting to explore whether pain behaviour also exhibits desensitization. The 1 O 2 generated by PpIX phototoxicity directly affects lipids by reacting with cis-double bonds in unsaturated fatty acids including arachidonic acid, 39 and this may lead to an increased production of additional TRPV1 active molecules. There are several oxidation products of arachidonic acid including 12(S)-hydroperoxyeicosatetraenoic acid, which is a TRPV1 agonist 9 and a possible participant in PpIX phototoxicity-evoked APs and pain.
A recent study demonstrated that blue light activates TRPV1 and TRPA1 channels, an effect that was enhanced by elevating PpIX levels. 1 The constitutive sensitivity of TRPA1 channels occurred over a range of wavelengths spanning UV A and visible blue light. Not only was blue light capable of activating TRPA1 channels, blue light irradiation of human skin in the absence of a photosensitizer was associated with pain. By contrast, the application of a photosensitizer is a prerequisite for pain associated with red light exposure in patients. 38 Furthermore, our observations demonstrate the requirement for the application of a photosensitizer and irradiation to initiate APs in DRG neurons and pain behaviour in mice. It is interesting that phototoxicity-evoked APs during irradiation by 630 nm light were resistant to the TRPA1 antagonist. This suggests that the causes of pain evoked by PDT with blue and red light may differ.
The in vitro and in vivo mouse models for PpIX-induced phototoxicity and pain provide approaches for identifying effective analgesic agents. We investigated menthol, which is commonly used for treating muscle pain. Recent studies suggest that menthol's analgesic actions are mediated through activation of TRPM8 channels, leading to the cooling sensation associated with menthol application, and through a local anaesthetic like state-dependent inhibition of voltage-activated Na 1 channels on DRG neurons. 23, 30 Indeed, the suppression of PpIX-evoked APs in DRG neurons by menthol could be explained by direct inhibition of voltage-activated Na 1 channels. Topical menthol also reduced PpIX phototoxicity pain behavior in mice, without affecting PpIX photoactivation. In the whole animal, the activation of TRPM8 receptors by menthol likely also contributes to analgesia by acting as a counterirritant and/or by engaging spinal gating mechanisms. 33, 42 Experiments in TRPM8 knockout mice would help establish the role played by these receptors in the analgesic action of menthol on PDT pain. However, this will require refinement of the behavioral model of PDT pain to use a tissue that is less pigmented in C57 mice, such as the paw pad perhaps.
Regardless of its mode of action, based on our findings, we anticipate that topical menthol will be effective for mitigating PpIXinduced pain, and this will have important implications for optimisation of PDT treatment for patients with skin cancers and precancers and for the management of patients with 
